understandingcontributesto clinical outcomes in multiple sclerosis ( MS
Using combined endpoints to define no evident disease activity ( NEDA ) is becoming increasingly commonwhen settingtargets for treatment outcomes in multiple sclerosis ( MS
the body 's defence system not working properly(passive) are caused bya review of the multiple sclerosis medicine Lemtrada ( alemtuzumab
These early datamay seta new bar for clinical outcomes in multiple sclerosis
The author JK Rowling has donated £ 10 mto setup a clinic to research treatments for multiple sclerosis
artificial sweeteners that are saidto causehealth problems like multiple sclerosis
Lonesome downloaddesigningrandomised trials in health , of Multiple Sclerosis
significant disability in young adultscausessignificant disability in young adults
significant physical impairment , including fatigue , pain , muscle spasms , tremors and dizzinesscan causesignificant physical impairment , including fatigue , pain , muscle spasms , tremors and dizziness
many symptoms , including loss of mobility , fatigue , and paincausesmany symptoms , including loss of mobility , fatigue , and pain
great links , shared by over 5,000 doctors , health experts , and advocates , and organized by specific health or healthy living topics like Multiple Sclerosis Medicationdiscovergreat links , shared by over 5,000 doctors , health experts , and advocates , and organized by specific health or healthy living topics like Multiple Sclerosis Medication
Programs(passive) designed byPrograms
the destruction of the covering ( myelin sheath ) of the nervescausesthe destruction of the covering ( myelin sheath ) of the nerves
to paralysis and deathleadsto paralysis and death
the decisionhave promptedthe decision
a disturbance of the blood vessels in the neckmay causea disturbance of the blood vessels in the neck